Pediatric Heart Failure

Pediatric heart failure is a significant challenge in clinical practice, a global burden worldwide. Compared to adult population, heart failure in children has a variety of etiologies depending on the patients age. However, pediatric heart failure guidelines are still extrapolated from adult...

Full description

Bibliographic Details
Main Authors: Iolanda Muntean, Asmaa Carla Barmou, Liliana Gozar, Amalia Fagarasan
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2021-03-01
Series:Romanian Journal of Pediatrics
Subjects:
Online Access:https://rjp.com.ro/articles/2021.1/RJP_2021_1_EN_Art-05.pdf
id doaj-1961cf770dd244928595432ec387b69f
record_format Article
spelling doaj-1961cf770dd244928595432ec387b69f2021-09-02T18:59:26ZengAmaltea Medical Publishing HouseRomanian Journal of Pediatrics1454-03982069-61752021-03-01701263010.37897/RJP.2021.1.5Pediatric Heart Failure Iolanda Muntean0Asmaa Carla Barmou1Liliana Gozar2Amalia Fagarasan3“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Tg. Mures, Romania ; Clinic of Pediatric Cardiology, Emergency Institute of Cardiovascular Diseases and Transplantation, Tg. Mures, RomaniaClinic of Pediatric Cardiology, Emergency Institute of Cardiovascular Diseases and Transplantation, Tg. Mures, Romania“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Tg. Mures, Romania ; Clinic of Pediatric Cardiology, Emergency Institute of Cardiovascular Diseases and Transplantation, Tg. Mures, Romania“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Tg. Mures, Romania ; Clinic of Pediatric Cardiology, Emergency Institute of Cardiovascular Diseases and Transplantation, Tg. Mures, RomaniaPediatric heart failure is a significant challenge in clinical practice, a global burden worldwide. Compared to adult population, heart failure in children has a variety of etiologies depending on the patients age. However, pediatric heart failure guidelines are still extrapolated from adult population. In infants and children, the pharmacological treatment is based on angiotensin-converting enzyme inhibitors, beta-blockers, aldosterone receptors antagonists, and other diuretics in the presence of congestion, with a lower use of device therapy. In end-stage heart failure, as a bridge to transplantation or recovery, ventricular assist devices or different palliative surgical interventions are used nowadays.This review focuses on the most important causes, pathophysiological mechanisms, clinical manifestation and management of pediatric heart faliure based on recent guidelines. Furthermore, it emphasize the newer pharmaco-logical or non-pharmacological therapies that have been recently approved in pediatric population. https://rjp.com.ro/articles/2021.1/RJP_2021_1_EN_Art-05.pdfpediatric heart failureclinical managementpharmacological treatamentmechanical assist devicesheart transplant
collection DOAJ
language English
format Article
sources DOAJ
author Iolanda Muntean
Asmaa Carla Barmou
Liliana Gozar
Amalia Fagarasan
spellingShingle Iolanda Muntean
Asmaa Carla Barmou
Liliana Gozar
Amalia Fagarasan
Pediatric Heart Failure
Romanian Journal of Pediatrics
pediatric heart failure
clinical management
pharmacological treatament
mechanical assist devices
heart transplant
author_facet Iolanda Muntean
Asmaa Carla Barmou
Liliana Gozar
Amalia Fagarasan
author_sort Iolanda Muntean
title Pediatric Heart Failure
title_short Pediatric Heart Failure
title_full Pediatric Heart Failure
title_fullStr Pediatric Heart Failure
title_full_unstemmed Pediatric Heart Failure
title_sort pediatric heart failure
publisher Amaltea Medical Publishing House
series Romanian Journal of Pediatrics
issn 1454-0398
2069-6175
publishDate 2021-03-01
description Pediatric heart failure is a significant challenge in clinical practice, a global burden worldwide. Compared to adult population, heart failure in children has a variety of etiologies depending on the patients age. However, pediatric heart failure guidelines are still extrapolated from adult population. In infants and children, the pharmacological treatment is based on angiotensin-converting enzyme inhibitors, beta-blockers, aldosterone receptors antagonists, and other diuretics in the presence of congestion, with a lower use of device therapy. In end-stage heart failure, as a bridge to transplantation or recovery, ventricular assist devices or different palliative surgical interventions are used nowadays.This review focuses on the most important causes, pathophysiological mechanisms, clinical manifestation and management of pediatric heart faliure based on recent guidelines. Furthermore, it emphasize the newer pharmaco-logical or non-pharmacological therapies that have been recently approved in pediatric population.
topic pediatric heart failure
clinical management
pharmacological treatament
mechanical assist devices
heart transplant
url https://rjp.com.ro/articles/2021.1/RJP_2021_1_EN_Art-05.pdf
work_keys_str_mv AT iolandamuntean pediatricheartfailure
AT asmaacarlabarmou pediatricheartfailure
AT lilianagozar pediatricheartfailure
AT amaliafagarasan pediatricheartfailure
_version_ 1721171165245865984